Calmodulin 2 抗体 (AA 1-149) (PerCP)
Quick Overview for Calmodulin 2 抗体 (AA 1-149) (PerCP) (ABIN5566490)
抗原
See all Calmodulin 2 (Calm2) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-149
- 
                                            品牌
- AssayLite™
- 
                                            产品特性
- Purified antibody validated for specificity and sensitivity.
- 
                                            纯化方法
- Affinity Purified
- 
                                            免疫原
- Human Calmodulin 2 (1-149aa) expressed in E. Coli.
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            缓冲液
- Lyophilized from PBS pH 7.4, 20 mg/mL BSA, and 0.02 % Sodium Azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - Calmodulin 2 (Calm2) (Calmodulin 2 (phosphorylase Kinase, Delta) (Calm2))
- 
                                            别名
- Calmodulin 2
- 
                                            基因ID
- 805
- 
                                            UniProt
- P62158
- 
                                            途径
- RTK signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cellular Glucan Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Phototransduction, Negative Regulation of Transporter Activity, VEGFR1 Specific Signals, BCR Signaling
 抗原
- 
                    
 
                                     
                                     
                                    